Telix Pharmaceuticals |
Market Cap (5-Oct) $5,151,129,600 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (29-Sep) 36,267,030 (10.67%) (12th) |
|
52w High $18.22 |
52w Low $8.26 |
P/E 140.85 |
EPS 0.14 |
[ARTICLE] Telix boss says Australia ‘horrible’ at getting drugs to patients
A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around , on 28 October 2024 at 2:26am.
Gift 5 articles to anyone you choose each month when you subscribe. Christian Behrenbruch, the co-founder and chief executive of $7 billion cancer diagnostic giant Telix Pharmaceuticals, has lashed out at Australia’s ability to make next-generation drugs ...
Read ArticleTLX was $11.22 at the close of trade on 30 June 2023
Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.